• Loading stock data…

Vor Bio to Participate in Upcoming Investor Conferences

Last Updated on August 1, 2022 by GlobeNewsWire

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

BTIG Biotechnology Conference 2022 (Hybrid)Fireside Chat: A pre-recorded fireside chat will be available via the conference website starting August 8, 2022 at 9:00 AM ET.

2022 Wedbush PacGrow Healthcare Conference (Virtual)Panel: A View to a Kill(er Cell) – Part 1Panel date/time: Wednesday, August 10, 2022, 1:10pm ET

A live webcast and archived replay of the panel will be available on the investors section of www.vorbio.com.

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com




Print Friendly, PDF & Email
Spread the word

Reader Interactions

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: